Analystreport

Windtree Therapeutics, Inc. (NASDAQ: WINT) is now covered by analysts at HC Wainwright. They set a "neutral" rating and a $1.00 price target on the stock.

Windtree Therapeutics, Inc.  (WINT) 
Last windtree therapeutics, inc. earnings: 8/21 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: windtreetx.investorroom.com